Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dae Yoon Chi

8PUBLICATIONS

40CO-AUTHORS

Pharmaceutical delivery technologiesOrganometallic chemistryGene and molecular therapyDiagnostic radiography

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 03, 2024

Preclinical evaluation of [<sup>18</sup>F]FP-CIT, the radiotracer targeting dopamine transporter for diagnosing Parkinson's disease: pharmacokinetic and efficacy analysis.

Jae Hun Ahn, Min Hwan Kim, Kyongkyu Lee

|Jan 30, 2024

Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [<sup>177</sup>Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer.

Seunggyun Ha, Joo Hyun O, Chansoo Park

|Dec 23, 2022

A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [<sup>177</sup>Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial.

Dongho Shin, Seunggyun Ha, Joo Hyun O

|Apr 15, 2022

Mechanistic study of nucleophilic fluorination for the synthesis of fluorine-18 labeled fluoroform with high molar activity from <i>N</i>-difluoromethyltriazolium triflate.

Jin Young Chai, Hyojin Cha, Sung-Sik Lee

|Nov 02, 2021

Improving Theranostic Gallium-68/Lutetium-177-Labeled PSMA Inhibitors with an Albumin Binder for Prostate Cancer.

Byoung Se Lee, Min Hwan Kim, So Young Chu

|Apr 27, 2021

Synthesis of aliphatic α-ketoamides from α-substituted methyl ketones <i>via</i> a Cu-catalyzed aerobic oxidative amidation.

Hyojin Cha, Jin Young Chai, Hyeong Baik Kim

Pageof 2

Frequent Collaborators

3 joint publications

Kyo Chul Lee

3 joint publications

Hee Seup Kil

2 joint publications

Jin Young Chai

2 joint publications

Ji Youl Lee

2 joint publications

Yong Jin Lee

2 joint publications

Hyojin Cha

2 joint publications

Hyong Woo Moon

2 joint publications

Joo Hyun O

2 joint publications

Min Hwan Kim

2 joint publications

Chansoo Park

Frequent Collaborators

3 joint publications

Kyo Chul Lee

3 joint publications

Hee Seup Kil

2 joint publications

Jin Young Chai

2 joint publications

Ji Youl Lee

Top Related Videos

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production

Published on : Oct 26, 2018

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on : Apr 24, 2020

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on : Sep 03, 2013

See more related videos

Top Related Videos

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production

Published on : Oct 26, 2018

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on : Apr 24, 2020

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on : Sep 03, 2013

See more related videos